Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heteroptera | 5 | 2024 | 13 | 3.260 |
Why?
|
Nanoparticles | 10 | 2024 | 232 | 3.050 |
Why?
|
Mammary Glands, Animal | 10 | 2025 | 481 | 2.250 |
Why?
|
Mammary Neoplasms, Experimental | 6 | 2025 | 247 | 2.060 |
Why?
|
Breast Neoplasms | 13 | 2025 | 2498 | 1.400 |
Why?
|
Metal Nanoparticles | 4 | 2024 | 42 | 1.300 |
Why?
|
Neoplasms | 6 | 2024 | 2765 | 1.300 |
Why?
|
Phylogeny | 5 | 2024 | 696 | 1.290 |
Why?
|
Phylogeography | 2 | 2024 | 16 | 1.130 |
Why?
|
Tumor Microenvironment | 4 | 2023 | 548 | 1.130 |
Why?
|
Animals | 49 | 2025 | 33999 | 1.110 |
Why?
|
Climate Change | 2 | 2024 | 42 | 1.080 |
Why?
|
Disease Models, Animal | 8 | 2025 | 4334 | 0.980 |
Why?
|
Magnetic Resonance Imaging | 4 | 2020 | 3549 | 0.950 |
Why?
|
Mice | 36 | 2025 | 17584 | 0.950 |
Why?
|
Gold | 1 | 2024 | 48 | 0.920 |
Why?
|
Energy Transfer | 2 | 2024 | 16 | 0.910 |
Why?
|
Optogenetics | 1 | 2024 | 69 | 0.910 |
Why?
|
Nanostructures | 3 | 2020 | 50 | 0.890 |
Why?
|
Biodiversity | 1 | 2024 | 64 | 0.890 |
Why?
|
Zinc | 1 | 2024 | 128 | 0.890 |
Why?
|
Epithelial Cells | 8 | 2024 | 908 | 0.880 |
Why?
|
Genetic Vectors | 4 | 2020 | 940 | 0.870 |
Why?
|
Dopaminergic Neurons | 1 | 2024 | 48 | 0.860 |
Why?
|
Hemiptera | 1 | 2023 | 10 | 0.860 |
Why?
|
Cranial Irradiation | 1 | 2024 | 67 | 0.850 |
Why?
|
Cerium | 2 | 2024 | 2 | 0.850 |
Why?
|
Mammary Neoplasms, Animal | 4 | 2018 | 139 | 0.820 |
Why?
|
Stem Cells | 4 | 2021 | 694 | 0.810 |
Why?
|
Carcinogenesis | 6 | 2021 | 332 | 0.800 |
Why?
|
Wound Infection | 1 | 2022 | 52 | 0.790 |
Why?
|
Gadolinium | 3 | 2020 | 104 | 0.780 |
Why?
|
Precancerous Conditions | 3 | 2023 | 282 | 0.780 |
Why?
|
Genome, Mitochondrial | 1 | 2022 | 30 | 0.770 |
Why?
|
Cell Transformation, Neoplastic | 7 | 2018 | 617 | 0.730 |
Why?
|
Gene Editing | 1 | 2023 | 187 | 0.720 |
Why?
|
Chlorine | 1 | 2020 | 15 | 0.710 |
Why?
|
Free Radicals | 1 | 2020 | 31 | 0.700 |
Why?
|
Photosensitizing Agents | 1 | 2020 | 34 | 0.690 |
Why?
|
Thermography | 1 | 2020 | 11 | 0.690 |
Why?
|
Glutathione | 3 | 2023 | 192 | 0.690 |
Why?
|
Wnt Signaling Pathway | 3 | 2021 | 192 | 0.670 |
Why?
|
Cysteine-Rich Protein 61 | 1 | 2019 | 5 | 0.650 |
Why?
|
Oncogenes | 4 | 2024 | 167 | 0.650 |
Why?
|
Mammary Tumor Virus, Mouse | 2 | 2018 | 106 | 0.640 |
Why?
|
Transfection | 2 | 2020 | 1059 | 0.630 |
Why?
|
Lentivirus | 5 | 2020 | 82 | 0.630 |
Why?
|
Antineoplastic Agents | 6 | 2020 | 1652 | 0.610 |
Why?
|
Insecta | 2 | 2022 | 58 | 0.600 |
Why?
|
Oxygen | 2 | 2018 | 553 | 0.590 |
Why?
|
DNA Helicases | 1 | 2019 | 231 | 0.570 |
Why?
|
Spinal Cord Injuries | 1 | 2020 | 311 | 0.560 |
Why?
|
Receptor, ErbB-2 | 5 | 2016 | 514 | 0.540 |
Why?
|
Keratin-6 | 4 | 2016 | 13 | 0.540 |
Why?
|
RNA, Long Noncoding | 1 | 2019 | 210 | 0.540 |
Why?
|
Nuclear Proteins | 3 | 2023 | 1266 | 0.530 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2020 | 1890 | 0.500 |
Why?
|
Skin Neoplasms | 2 | 2020 | 809 | 0.490 |
Why?
|
RNA, Ribosomal | 2 | 2012 | 63 | 0.480 |
Why?
|
Gene Transfer Techniques | 2 | 2023 | 356 | 0.470 |
Why?
|
Neurons | 1 | 2024 | 1954 | 0.460 |
Why?
|
China | 3 | 2024 | 243 | 0.450 |
Why?
|
RNA, Ribosomal, 28S | 1 | 2013 | 4 | 0.420 |
Why?
|
Mice, Transgenic | 9 | 2023 | 2389 | 0.420 |
Why?
|
DNA, Mitochondrial | 2 | 2024 | 210 | 0.410 |
Why?
|
Wnt Proteins | 1 | 2013 | 193 | 0.410 |
Why?
|
Rats | 3 | 2025 | 3674 | 0.400 |
Why?
|
Melanoma | 1 | 2019 | 835 | 0.390 |
Why?
|
Archaea | 1 | 2012 | 10 | 0.390 |
Why?
|
Eukaryota | 1 | 2012 | 21 | 0.390 |
Why?
|
Lung Neoplasms | 2 | 2018 | 1594 | 0.390 |
Why?
|
CRISPR-Cas Systems | 2 | 2025 | 254 | 0.370 |
Why?
|
Cell Nucleus | 2 | 2024 | 675 | 0.370 |
Why?
|
Ribosomes | 1 | 2012 | 137 | 0.370 |
Why?
|
Action Potentials | 2 | 2024 | 500 | 0.370 |
Why?
|
Bayes Theorem | 3 | 2022 | 283 | 0.360 |
Why?
|
Cell Line, Tumor | 13 | 2023 | 3330 | 0.350 |
Why?
|
Neoplasms, Experimental | 1 | 2011 | 209 | 0.340 |
Why?
|
Protein Array Analysis | 2 | 2022 | 101 | 0.340 |
Why?
|
Retroviridae | 3 | 2023 | 198 | 0.330 |
Why?
|
Silicon Dioxide | 3 | 2020 | 24 | 0.320 |
Why?
|
Transcription Factors | 1 | 2019 | 2584 | 0.320 |
Why?
|
Female | 30 | 2025 | 66274 | 0.300 |
Why?
|
Epithelial-Mesenchymal Transition | 3 | 2019 | 214 | 0.260 |
Why?
|
Cell Plasticity | 2 | 2017 | 32 | 0.260 |
Why?
|
Janus Kinase 2 | 2 | 2018 | 131 | 0.250 |
Why?
|
beta Catenin | 3 | 2023 | 204 | 0.250 |
Why?
|
Genes, Reporter | 4 | 2020 | 381 | 0.240 |
Why?
|
Polyethylene Glycols | 2 | 2018 | 224 | 0.240 |
Why?
|
Porphyrins | 1 | 2024 | 16 | 0.240 |
Why?
|
Humans | 30 | 2025 | 124143 | 0.240 |
Why?
|
Electrodes | 1 | 2024 | 98 | 0.230 |
Why?
|
Keratoderma, Palmoplantar | 1 | 2024 | 5 | 0.230 |
Why?
|
Animal Distribution | 1 | 2024 | 10 | 0.230 |
Why?
|
Cell Proliferation | 8 | 2020 | 2283 | 0.230 |
Why?
|
Serpins | 1 | 2024 | 27 | 0.230 |
Why?
|
Epidermis | 1 | 2024 | 63 | 0.230 |
Why?
|
Benzopyrans | 1 | 2024 | 19 | 0.220 |
Why?
|
Motor Cortex | 1 | 2024 | 77 | 0.220 |
Why?
|
Diffusion | 1 | 2024 | 57 | 0.220 |
Why?
|
Light | 1 | 2024 | 176 | 0.220 |
Why?
|
Cell Survival | 4 | 2020 | 801 | 0.220 |
Why?
|
Cysteine Endopeptidases | 1 | 2024 | 114 | 0.220 |
Why?
|
Hydrogen Peroxide | 3 | 2023 | 112 | 0.210 |
Why?
|
Recombinational DNA Repair | 1 | 2023 | 16 | 0.210 |
Why?
|
Boron | 1 | 2022 | 3 | 0.210 |
Why?
|
Peptidoglycan | 1 | 2022 | 16 | 0.210 |
Why?
|
Biological Evolution | 1 | 2024 | 225 | 0.210 |
Why?
|
Surface Properties | 2 | 2020 | 82 | 0.210 |
Why?
|
Drug Screening Assays, Antitumor | 2 | 2020 | 92 | 0.210 |
Why?
|
Boron Compounds | 1 | 2022 | 32 | 0.200 |
Why?
|
Particle Size | 2 | 2020 | 121 | 0.200 |
Why?
|
India | 1 | 2023 | 214 | 0.200 |
Why?
|
Proteogenomics | 1 | 2023 | 67 | 0.200 |
Why?
|
CD40 Ligand | 1 | 2022 | 64 | 0.200 |
Why?
|
Neoptera | 1 | 2022 | 1 | 0.200 |
Why?
|
Thiazoles | 1 | 2023 | 98 | 0.200 |
Why?
|
Microbubbles | 1 | 2022 | 7 | 0.200 |
Why?
|
Endometrial Neoplasms | 1 | 2023 | 97 | 0.200 |
Why?
|
Acoustics | 1 | 2022 | 20 | 0.200 |
Why?
|
Microtubule-Associated Proteins | 1 | 2023 | 243 | 0.200 |
Why?
|
Neoplastic Stem Cells | 2 | 2014 | 295 | 0.190 |
Why?
|
Drug Carriers | 2 | 2023 | 100 | 0.190 |
Why?
|
Nucleic Acid Conformation | 2 | 2013 | 184 | 0.190 |
Why?
|
Electric Impedance | 1 | 2022 | 57 | 0.190 |
Why?
|
Temperature | 2 | 2020 | 304 | 0.190 |
Why?
|
Metformin | 1 | 2023 | 150 | 0.190 |
Why?
|
Lipopolysaccharides | 1 | 2022 | 283 | 0.180 |
Why?
|
Rats, Transgenic | 1 | 2020 | 15 | 0.180 |
Why?
|
Infrared Rays | 1 | 2020 | 24 | 0.180 |
Why?
|
Silver | 1 | 2020 | 21 | 0.180 |
Why?
|
DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2020 | 24 | 0.180 |
Why?
|
Inhibitor of Differentiation Proteins | 1 | 2020 | 11 | 0.170 |
Why?
|
Neuroprotection | 1 | 2020 | 25 | 0.170 |
Why?
|
STAT5 Transcription Factor | 2 | 2018 | 89 | 0.170 |
Why?
|
Mixed Function Oxygenases | 1 | 2020 | 30 | 0.170 |
Why?
|
Receptors, Estrogen | 2 | 2021 | 796 | 0.170 |
Why?
|
Sodium Fluoride | 1 | 2020 | 12 | 0.170 |
Why?
|
Neoplasm Invasiveness | 2 | 2019 | 611 | 0.170 |
Why?
|
Anti-Bacterial Agents | 1 | 2012 | 2420 | 0.170 |
Why?
|
Hyperthermia, Induced | 2 | 2018 | 49 | 0.170 |
Why?
|
HEK293 Cells | 2 | 2020 | 743 | 0.170 |
Why?
|
Adenoviridae | 1 | 2023 | 605 | 0.170 |
Why?
|
Spine | 1 | 2020 | 143 | 0.170 |
Why?
|
Bismuth | 1 | 2020 | 79 | 0.170 |
Why?
|
Plasmids | 1 | 2020 | 510 | 0.160 |
Why?
|
Sepsis | 1 | 2024 | 468 | 0.160 |
Why?
|
Theranostic Nanomedicine | 2 | 2017 | 5 | 0.160 |
Why?
|
Computational Biology | 3 | 2014 | 811 | 0.160 |
Why?
|
Models, Genetic | 2 | 2013 | 759 | 0.160 |
Why?
|
Wound Healing | 1 | 2022 | 435 | 0.160 |
Why?
|
Mitochondria | 1 | 2024 | 678 | 0.160 |
Why?
|
A549 Cells | 1 | 2018 | 42 | 0.160 |
Why?
|
Bacteria | 1 | 2022 | 484 | 0.160 |
Why?
|
Inflammation | 2 | 2024 | 1423 | 0.160 |
Why?
|
Spleen | 1 | 2019 | 281 | 0.150 |
Why?
|
Metabolic Networks and Pathways | 1 | 2019 | 187 | 0.150 |
Why?
|
Juglandaceae | 1 | 2018 | 1 | 0.150 |
Why?
|
Copper | 1 | 2018 | 58 | 0.150 |
Why?
|
Wnt1 Protein | 1 | 2018 | 71 | 0.150 |
Why?
|
Cell Movement | 2 | 2019 | 832 | 0.150 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2019 | 288 | 0.150 |
Why?
|
Histones | 1 | 2022 | 525 | 0.150 |
Why?
|
Diptera | 1 | 2018 | 22 | 0.150 |
Why?
|
Recovery of Function | 1 | 2020 | 440 | 0.150 |
Why?
|
Cysteine | 1 | 2018 | 135 | 0.150 |
Why?
|
Magnetic Fields | 1 | 2018 | 6 | 0.150 |
Why?
|
Sequence Analysis, DNA | 1 | 2024 | 1748 | 0.150 |
Why?
|
Cell Differentiation | 3 | 2024 | 1889 | 0.150 |
Why?
|
Base Sequence | 2 | 2013 | 3089 | 0.140 |
Why?
|
Naphthoquinones | 1 | 2017 | 5 | 0.140 |
Why?
|
Electrochemical Techniques | 1 | 2017 | 6 | 0.140 |
Why?
|
Twist-Related Protein 1 | 1 | 2017 | 36 | 0.140 |
Why?
|
DNA-Binding Proteins | 2 | 2020 | 2047 | 0.140 |
Why?
|
Genetic Variation | 1 | 2024 | 1493 | 0.140 |
Why?
|
Biosensing Techniques | 1 | 2017 | 48 | 0.140 |
Why?
|
Molecular Sequence Data | 2 | 2013 | 3872 | 0.140 |
Why?
|
Bone Density Conservation Agents | 1 | 2017 | 51 | 0.140 |
Why?
|
Proto-Oncogene Proteins | 1 | 2020 | 545 | 0.140 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2017 | 99 | 0.130 |
Why?
|
Iron Compounds | 1 | 2016 | 2 | 0.130 |
Why?
|
Mice, Inbred BALB C | 4 | 2021 | 992 | 0.130 |
Why?
|
X-Rays | 1 | 2015 | 27 | 0.120 |
Why?
|
Colorectal Neoplasms | 1 | 2021 | 564 | 0.120 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2024 | 2629 | 0.120 |
Why?
|
Apoptosis | 6 | 2021 | 1778 | 0.120 |
Why?
|
Oxidative Stress | 1 | 2020 | 798 | 0.120 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2020 | 662 | 0.120 |
Why?
|
Signal Transduction | 6 | 2020 | 4498 | 0.120 |
Why?
|
Claudins | 1 | 2014 | 29 | 0.120 |
Why?
|
Mammary Glands, Human | 1 | 2015 | 78 | 0.120 |
Why?
|
Structure-Activity Relationship | 2 | 2016 | 574 | 0.120 |
Why?
|
Cells, Cultured | 2 | 2018 | 3028 | 0.110 |
Why?
|
GTP Phosphohydrolases | 1 | 2015 | 144 | 0.110 |
Why?
|
Mice, Nude | 4 | 2018 | 707 | 0.110 |
Why?
|
Interleukin-8 | 1 | 2015 | 209 | 0.110 |
Why?
|
Tungsten Compounds | 1 | 2013 | 3 | 0.110 |
Why?
|
MAP Kinase Kinase Kinase 3 | 1 | 2014 | 9 | 0.110 |
Why?
|
Ischemia | 1 | 2017 | 354 | 0.110 |
Why?
|
Blood Vessels | 1 | 2014 | 102 | 0.110 |
Why?
|
Phototherapy | 1 | 2013 | 34 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2013 | 39 | 0.110 |
Why?
|
Iron | 1 | 2016 | 264 | 0.110 |
Why?
|
Gene Amplification | 1 | 2014 | 228 | 0.100 |
Why?
|
Phosphorylation | 4 | 2024 | 1613 | 0.100 |
Why?
|
DNA, Ribosomal | 1 | 2013 | 55 | 0.100 |
Why?
|
Nanotechnology | 1 | 2013 | 49 | 0.100 |
Why?
|
Protein Kinase C-epsilon | 1 | 2012 | 12 | 0.100 |
Why?
|
Bone Neoplasms | 1 | 2017 | 416 | 0.100 |
Why?
|
STAT3 Transcription Factor | 1 | 2014 | 221 | 0.100 |
Why?
|
Liver | 1 | 2019 | 1733 | 0.100 |
Why?
|
Thyroid Hormones | 1 | 2012 | 67 | 0.100 |
Why?
|
Molecular Imaging | 1 | 2013 | 61 | 0.100 |
Why?
|
Nitric Oxide | 1 | 2015 | 440 | 0.100 |
Why?
|
RNA, Ribosomal, 18S | 1 | 2012 | 18 | 0.100 |
Why?
|
Peptidyl Transferases | 1 | 2012 | 6 | 0.100 |
Why?
|
Contig Mapping | 1 | 2012 | 55 | 0.100 |
Why?
|
Conserved Sequence | 1 | 2013 | 291 | 0.100 |
Why?
|
Likelihood Functions | 1 | 2012 | 113 | 0.100 |
Why?
|
Cisplatin | 1 | 2013 | 234 | 0.100 |
Why?
|
Base Pairing | 1 | 2012 | 42 | 0.100 |
Why?
|
Monte Carlo Method | 1 | 2012 | 95 | 0.090 |
Why?
|
Avian Leukosis Virus | 1 | 2011 | 14 | 0.090 |
Why?
|
Sequence Alignment | 1 | 2013 | 623 | 0.090 |
Why?
|
ErbB Receptors | 1 | 2012 | 284 | 0.090 |
Why?
|
Triple Negative Breast Neoplasms | 1 | 2014 | 235 | 0.090 |
Why?
|
Oxidation-Reduction | 2 | 2023 | 438 | 0.090 |
Why?
|
NF-kappa B | 1 | 2012 | 450 | 0.090 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2014 | 723 | 0.080 |
Why?
|
Chromatin | 2 | 2023 | 552 | 0.080 |
Why?
|
I-kappa B Kinase | 2 | 2024 | 60 | 0.080 |
Why?
|
Glioblastoma | 1 | 2012 | 326 | 0.080 |
Why?
|
Binding Sites | 1 | 2012 | 1293 | 0.080 |
Why?
|
Saccharomyces cerevisiae | 1 | 2012 | 426 | 0.080 |
Why?
|
Mice, Knockout | 4 | 2024 | 3720 | 0.080 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2013 | 718 | 0.080 |
Why?
|
Neoplasm Transplantation | 3 | 2014 | 371 | 0.080 |
Why?
|
Evolution, Molecular | 1 | 2012 | 672 | 0.080 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 2008 | 88 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2018 | 1309 | 0.070 |
Why?
|
Carrier Proteins | 1 | 2012 | 1022 | 0.070 |
Why?
|
Software | 1 | 2012 | 677 | 0.070 |
Why?
|
Tumor Suppressor Proteins | 1 | 2010 | 464 | 0.070 |
Why?
|
Adenocarcinoma | 1 | 2014 | 1008 | 0.070 |
Why?
|
DNA Damage | 1 | 2010 | 512 | 0.070 |
Why?
|
Keratins | 1 | 2006 | 55 | 0.070 |
Why?
|
Escherichia coli | 1 | 2012 | 986 | 0.070 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2017 | 430 | 0.060 |
Why?
|
Cell Cycle Proteins | 1 | 2010 | 641 | 0.060 |
Why?
|
Brain | 1 | 2017 | 2977 | 0.060 |
Why?
|
Mice, SCID | 2 | 2018 | 565 | 0.060 |
Why?
|
Membrane Proteins | 1 | 2012 | 1527 | 0.060 |
Why?
|
Doxorubicin | 2 | 2018 | 290 | 0.060 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2018 | 882 | 0.050 |
Why?
|
Polyphenols | 1 | 2023 | 19 | 0.050 |
Why?
|
Electrons | 1 | 2023 | 24 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2012 | 1210 | 0.050 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2014 | 96 | 0.050 |
Why?
|
Estrogen Receptor Modulators | 1 | 2023 | 38 | 0.050 |
Why?
|
Green Fluorescent Proteins | 2 | 2014 | 390 | 0.050 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2023 | 73 | 0.050 |
Why?
|
Hyperplasia | 1 | 2023 | 207 | 0.050 |
Why?
|
Ubiquitination | 2 | 2013 | 168 | 0.050 |
Why?
|
Time Factors | 1 | 2012 | 6281 | 0.050 |
Why?
|
Male | 4 | 2021 | 60992 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2021 | 172 | 0.040 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2021 | 152 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2023 | 481 | 0.040 |
Why?
|
Reactive Oxygen Species | 1 | 2023 | 481 | 0.040 |
Why?
|
Protein Processing, Post-Translational | 1 | 2022 | 353 | 0.040 |
Why?
|
Dioxygenases | 1 | 2020 | 47 | 0.040 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2020 | 80 | 0.040 |
Why?
|
Ultraviolet Rays | 1 | 2020 | 201 | 0.040 |
Why?
|
Middle Aged | 1 | 2019 | 26587 | 0.040 |
Why?
|
Hydroxyl Radical | 1 | 2018 | 9 | 0.040 |
Why?
|
Carya | 1 | 2018 | 1 | 0.040 |
Why?
|
Adult | 1 | 2019 | 29339 | 0.040 |
Why?
|
Pimozide | 1 | 2018 | 6 | 0.040 |
Why?
|
Hyperprolactinemia | 1 | 2018 | 23 | 0.040 |
Why?
|
Mice, Inbred NOD | 1 | 2018 | 283 | 0.040 |
Why?
|
Asia | 1 | 2018 | 107 | 0.040 |
Why?
|
Ferric Compounds | 1 | 2018 | 36 | 0.040 |
Why?
|
Risperidone | 1 | 2018 | 59 | 0.040 |
Why?
|
Luminescent Agents | 1 | 2017 | 7 | 0.040 |
Why?
|
Transforming Growth Factor beta | 1 | 2020 | 456 | 0.040 |
Why?
|
Osteocytes | 1 | 2017 | 15 | 0.040 |
Why?
|
Epigenesis, Genetic | 1 | 2022 | 674 | 0.030 |
Why?
|
Intestines | 1 | 2021 | 573 | 0.030 |
Why?
|
Delayed-Action Preparations | 1 | 2017 | 110 | 0.030 |
Why?
|
Promoter Regions, Genetic | 2 | 2012 | 1328 | 0.030 |
Why?
|
Optical Imaging | 1 | 2017 | 66 | 0.030 |
Why?
|
Breast | 1 | 2018 | 215 | 0.030 |
Why?
|
Drug Delivery Systems | 1 | 2017 | 186 | 0.030 |
Why?
|
Glass | 1 | 2016 | 12 | 0.030 |
Why?
|
Antigens, Viral, Tumor | 1 | 2015 | 47 | 0.030 |
Why?
|
MCF-7 Cells | 1 | 2016 | 222 | 0.030 |
Why?
|
Equipment Design | 1 | 2017 | 586 | 0.030 |
Why?
|
Genes, ras | 1 | 2015 | 99 | 0.030 |
Why?
|
Virus Latency | 1 | 2015 | 61 | 0.030 |
Why?
|
Antipsychotic Agents | 1 | 2018 | 361 | 0.030 |
Why?
|
Spheroids, Cellular | 1 | 2014 | 57 | 0.030 |
Why?
|
Fluorescence | 1 | 2014 | 95 | 0.030 |
Why?
|
Cell Tracking | 1 | 2014 | 15 | 0.030 |
Why?
|
Virion | 1 | 2015 | 147 | 0.030 |
Why?
|
Cell Hypoxia | 1 | 2014 | 94 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2018 | 1223 | 0.030 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2014 | 23 | 0.030 |
Why?
|
Microscopy, Fluorescence, Multiphoton | 1 | 2014 | 38 | 0.030 |
Why?
|
Disease Progression | 1 | 2020 | 2046 | 0.030 |
Why?
|
Colony-Forming Units Assay | 1 | 2014 | 68 | 0.030 |
Why?
|
DNA Methylation | 1 | 2020 | 1002 | 0.030 |
Why?
|
Materials Testing | 1 | 2013 | 73 | 0.030 |
Why?
|
Heterografts | 1 | 2014 | 171 | 0.030 |
Why?
|
Etoposide | 1 | 2014 | 114 | 0.030 |
Why?
|
Fluorouracil | 1 | 2014 | 126 | 0.030 |
Why?
|
Cell Lineage | 1 | 2015 | 338 | 0.030 |
Why?
|
MAP Kinase Kinase Kinase 1 | 1 | 2013 | 13 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase 9 | 1 | 2013 | 14 | 0.030 |
Why?
|
Organosilicon Compounds | 1 | 2013 | 2 | 0.030 |
Why?
|
Colloids | 1 | 2013 | 17 | 0.030 |
Why?
|
Porosity | 1 | 2013 | 38 | 0.030 |
Why?
|
Transduction, Genetic | 1 | 2014 | 290 | 0.030 |
Why?
|
Polypyrimidine Tract-Binding Protein | 1 | 2012 | 10 | 0.030 |
Why?
|
Caspase 9 | 1 | 2013 | 75 | 0.030 |
Why?
|
Phospholipase C gamma | 1 | 2012 | 19 | 0.030 |
Why?
|
Microscopy, Confocal | 1 | 2014 | 348 | 0.030 |
Why?
|
Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2012 | 25 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2014 | 354 | 0.030 |
Why?
|
Transcription Factor RelA | 1 | 2012 | 52 | 0.030 |
Why?
|
Prospective Studies | 1 | 2023 | 6121 | 0.030 |
Why?
|
Mice, Inbred C57BL | 1 | 2021 | 4392 | 0.020 |
Why?
|
Epidermal Growth Factor | 1 | 2012 | 121 | 0.020 |
Why?
|
Erythrocytes | 1 | 2013 | 212 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2012 | 316 | 0.020 |
Why?
|
Glycolysis | 1 | 2012 | 148 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2014 | 762 | 0.020 |
Why?
|
Lactic Acid | 1 | 2012 | 153 | 0.020 |
Why?
|
HeLa Cells | 1 | 2013 | 806 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2016 | 1683 | 0.020 |
Why?
|
Serine | 1 | 2012 | 173 | 0.020 |
Why?
|
Neoplasm Grading | 1 | 2012 | 274 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2012 | 254 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2012 | 619 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2014 | 676 | 0.020 |
Why?
|
RNA Interference | 1 | 2012 | 494 | 0.020 |
Why?
|
Mutation | 2 | 2016 | 5818 | 0.020 |
Why?
|
Up-Regulation | 1 | 2012 | 859 | 0.020 |
Why?
|
Ataxia Telangiectasia Mutated Proteins | 1 | 2010 | 95 | 0.020 |
Why?
|
Fibroblasts | 1 | 2014 | 875 | 0.020 |
Why?
|
Models, Biological | 1 | 2014 | 1453 | 0.020 |
Why?
|
Keratin-9 | 1 | 2008 | 3 | 0.020 |
Why?
|
Alpharetrovirus | 1 | 2008 | 5 | 0.020 |
Why?
|
Cell Line | 1 | 2013 | 2734 | 0.020 |
Why?
|
Cellular Senescence | 1 | 2010 | 161 | 0.020 |
Why?
|
NIH 3T3 Cells | 1 | 2008 | 93 | 0.020 |
Why?
|
Cell Transformation, Viral | 1 | 2008 | 106 | 0.020 |
Why?
|
Glucose | 1 | 2012 | 879 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2014 | 2863 | 0.020 |
Why?
|
HIV | 1 | 2008 | 180 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2013 | 2089 | 0.020 |
Why?
|
Receptors, Steroid | 1 | 2006 | 275 | 0.010 |
Why?
|
Risk Factors | 1 | 2018 | 10244 | 0.010 |
Why?
|
Prognosis | 1 | 2012 | 4609 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2006 | 996 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2006 | 1699 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2013 | 12286 | 0.010 |
Why?
|